37

DAFTAR PUSTAKA

1. WHO. Causes of Death 2008 Summary Tables Geneva: Health Statistics and Informatics Department-World Health Organization; 2011. 2. Depkes RI. Laporan Riset Kesehatan Dasar (Riskesda) 2007 Jakarta: Badan Penelitian dan Pengembangan Kesehatan; 2008. 3. Delima , Mihardja L, Siswoyo H. Prevalensi dan Faktor Determinan Penyakit Jantung di Indonesia. Buletin Peneliti Kesehatan. 2008; 37: p. 152-49. 4. Dominique A. Cost-Effective Prevention of Coronary Heart Disease. The Journal for Nurse Practitioners. 2010 November; 6(10): p. 754-64. 5. Alan SG, Mozaffarian D, Vronique LR, Emelia JB, Jarett DB. Heart Disease and Stroke Statistics-2013 Update : A Report From the American Heart Association. Circulation. 2012 December; 127: p. e6-e245. 6. O'Gara PT, Kushner FG, Ascheim DD, Casey DEJ, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction :A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2012 Descember; 127: p. e362-e425. 7. Robert CW, Ornato J, Paul WA. Prehospital Management of Acute STElevation Myocardial Infarction: A Time for Reappraisal in North America. American Heart Journal. 2003 January; 145: p. 1-8. 8. Assaad JS, Matthew TR. The Role of Fibrinolytics in the Prehospital Treatment of ST-Elevation Myocardial Infarction (STEMI). Journal of Emergency Medicine. 2008; 34(4): p. 405-16. 9. Langer A, Mitchell WK, Klootwijk P, Maarten LS, Christhoper BG, Barr A, et al. Prognostic Significance of ST Segment Shift Early After Resolution of ST Elevation in Patients With Myocardial Infarction Treated With Thrombolytic Therapy: The GUSTO-I ST Segment Monitoring Substudy. J Am Coll Cardiol. 1998; 31: p. 738-9. 10. Dennis TW, Puri R, James DR, Matthew IW, Stephen GW. Myocardial NoReflow Diagnosis, Pathophysiology and Treatment. International Journal of Cardiology. 2013;: p. 1-9. 11. Bonnow RO, Mann DL, Zipes DP, Libby P. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 9th ed. Philadelphia: Saunders Elsevier; 2012.

38

12. Libby P. Molecular bases of the acute coronary syndromes. Circulation. 1995; 91: p. 2844-2850. 13. Marytha R. Patofisiologi Sindrom Koroner Akut. Cermin Dunia Kedokteran. 2012 Oktober; 39(4): p. 261-264. 14. Kumar A, Canon CP. Acute Coronary Syndromes: Diagnosis and Management Part I. Mayo Clin Proc. 2009; 84(10): p. 917-938. 15. Barsness GW, Holmes Jr DR. Coronary Artery Disease: New Approaches without Traditional Revascularization New York: Springer-Verlag; 2012. 16. Gelfand EV, Cannon CP. Management of Acute Coronary Syndromes West Sussex: Wiley Blackwell; 2009. 17. Kumar V, Cotran RS, Robbins SL. Buku Ajar Patologi Robbins. 7th ed. Jakarta: EGC; 2007. 18. Kumar V, Abbas AK, Fausto N, Aster JC. Robbins Basic Pathology. 8th ed. Philadelphia: Elsevier Saunders; 2012. 19. Schwartz RS, Burke A, Farb A, Kaye D, Lesser JR, Henry TD, et al. Microemboli and Microvascular Obstruction in Acute Coronary Thrombosis and Sudden Coronary Death: Relation to Epicardial Plaque Histopathology. Journal of the American College of Cardiology. 2009 December; 54(32): p. 2167-2173. 20. Bavry AA, Bhatt DL. Acute Coronary Syndrome in Clinical Practice London: Springer-Verlag; 2009. 21. Nucleus Medical Media. Plaque Rupture and Heart Attack. [Online].; 2009 [cited 2013 Juny 25. Available from: http://ebsco.smartimagebase.com/plaque-rupture-and-heart-attack/viewitem?ItemID=30468. 22. Surez-Barrientos A, Lpez-Romero P, Vivas D, Castro-Ferreira F, NnezGil I, Franco E, et al. Circadian Variations of Infarct Size in Acute Myocardial Infarction. Heart. 2011; 97: p. 970-976. 23. Jiddou M, Pica M, Boura J, Qu L, Franklin B. Incidence of Myocardial Infarction With Shifts to and From Daylight Savings Time. Am J Cardiol. 2013; 111: p. 631-635.

39

24. Siska. Derajat Keparahan Infark Miokard Akut Berdasarkan Waktu Serangan Pada Penderita Iinfark Miokard Akut di RSUD dr. Zainoel Abidin Banda Aceh. Skripsi. Banda Aceh: Universitas Syiah Kuala, Fakultas Kedokteran; 2013. 25. Steg G, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA. ESC Guidelines for The Management of Acute Myocardial Infarction in Patients Presenting with ST-Segment Elevation. European Heart Journal. 2012; 33: p. 25692619. 26. Sudoyo AW, Setiyohadi B, Alwi I, Simadibrata M, Setiati S. Buku Ajar Ilmu Penyakit Dalam. 5th ed. Jakarta: Interna Publishing; 2010. 27. Brodie BR. Comparison of Reperfusion Strategies for ST Elevation Acute Myocardial Infarction: Primary Coronary Intervention Versus Fibrinolysis London: Springer; 2009. 28. Bawamia B, Mehran R, Qiu W, Kunadian V. Risk Scores in Acute Coronary Syndrome and Percutaneous Coronary Intervention: A Review. American Heart Journal. 2013 April;: p. 441-450. 29. Eko A. Streptokinase pada Infark Miokard Akut di RSJHK. Tesis. Jakarta: Universitas Indonesia, Fakultas Kedokteran; 2007. 30. A G C Sutton PCG, Price DJA, Grech ED, Hall JA, Davies A, Stewart MJ, et al. Failure of Thrombolysis by Streptokinase: Detection With a Simple Electrocardiographic Method. Heart. 2000; 84: p. 149-156. 31. Harkness JR, Sabatine MS, Braunwald E, Morrow DA, Sloan S. Extent of STSegment Resolution After Fibrinolysis Adds Improved Risk Stratification to Clinical Risk Score for ST-Segment Elevation Myocardial Infarction. American Heart Journal. 2010 January; 159: p. 55-62. 32. Guyton AC, Hall JE. Buku Ajar Fisiologi Kedokteran. 11th ed. Jakarta: EGC; 2007. 33. Hoffman R, Benz EJ, Shattil SJFB, Cohen HJ, Silberstein LE, McGlave P. Hematology: Basic Principles and Practice Philadelphia, Pennsylvania: Elsevier; 2007. 34. Lichtman MA, Beutler E, Kipps TJ, Seligsohn U, Kaushansky K, Prchal JT. Williams Hematology. 7th ed. New York: The McGraw-Hill Companies; 2008.

40

35. Guyton AC, Hall JE. Textbook of Medical Physiology. 11th ed. Philadelphia, Pennsylvania: Elsevier; 2006. 36. Hoffbrand V, Moss P. Essential Haematology. 6th ed. Oxford: WileyBlacwell; 2011. 37. McPherson RA, Pincus MR. HENRYS Clinical Diagnosis and Management by Laboratory Methods. 22nd ed. Philadelphia: Elsevier Saunders; 2011. 38. Sacher RA, Pherson RA. Tinjauan Klinis Hasil Pemeriksaan Laboratorium Jakarta: EGC; 2005. 39. Jialing F, Tarou W. Inflamatory Reaction in Pathogenesis Atherosclerosis. J Atheros Trombus. 2007; 10: p. 63-69. 40. Russel R. Artherosclerosis an Inflamatory Disease. N Engl J Med. 199;: p. 115-125. 41. Reffelmann T, Kloner R. The No-Reflow Phenomenon: A Basic Mechanism of Myocardial Ischemia and Reperfusion. Basic Res Cardiol 2006;101:359 72. 2006; 101: p. 359-372. 42. Ito B, Schmid-Schonbein G, Engler R. Effects of Leukocyte Activation on Myocardial Vascular Resistance. Blood Cells. 1990; 16: p. 145163. 43. Niccoli GBF, Galiuto L, Crea F. Myocardial no-reflow in humans. J Am Coll Cardiol. 2009; 54: p. 281-292. 44. Takahashi T, Hiasa Y, Ohara Y. Relation Between Neutrophil Counts on Admission, Microvascular Injury, and Left Ventricular Functional Recovery in Patients With an Anterior Wall First Acute Myocardial Infarction Treated With Primary Coronary Angioplasty. Am J Cardiol 2007. 2007; 100: p. 35-40. 45. Murray RK, Granner DK, Rodwell VW. Biokimia Harper. 27th ed. Jakarta: EGC; 2009. 46. Bauters C, Lamblin N, Fadden E, Belle E, Millare A, Groote P. Influence of Diabetes Mellitus on Heart Failure Risk and Outcome. Cardiovascular Diabetology. 2003 January; 8: p. 1-16. 47. Liu J, Sempos C, Donahue R. Joint Distribution of Non-HDL and LDL Cholesterol and Coronary Heart Disease Risk Prediction Among Individuals With and Without Diabetes. Diabetes Care. 2005 August 8; 28(28): p. 1916-

41

1921. 48. Collet J, Montalescot G. The Acute Reperfusion Management of STEMI in Patients with Impaired Glucose Tolerance and Type 2 Diabetes. Diab Vasc Dis Res. 2005; 2: p. 136-143. 49. Golino P, Maroko P, Carew T. The Effect of Acute Hypercholesterolemia on Myocardial Infarct Size and The No-Reflow Phenomenon During Coronary Occlusion-Reperfusion. Circulation. 1987; 75: p. 292-298. 50. Malmberg K, Ryden L, Efendic S. Randomized Trial of Insulin-Glucose Infusion Followed by Subcutaneous Insulin Treatment in Diabetic Patients with Acute Myocardial Infarction (DIGAMI Study): Effects on Mortality at 1 Year. J Am Coll Cardiol. 1995; 26: p. 57-65. 51. Ganong WF. Review of Medical Physiology. 22nd ed. San Fransico: McGraw-Hill Companies; 2005. 52. Iwakura K, Ito H, Kawano S. Chronic Pre-Treatment of Statins is Associated with The Reduction of The No-Reflow Phenomenon in The Patients With Reperfused Acute Myocardial Infarction. Eur Heart J 2006. 2006; 27: p. 534539. 53. Gresele P, Fuster V, Lopez JA, Page CP, Vermylen J. Platelets in Hematologic and Cardiovascular Disorders: A Clinical Handbook Cambridge: Cambridge University Press; 2008. 54. Jurk K, Kehrel BE. Platelets:Physiology and Biochemistry. Thrombosis and Hemostasis. 2005; 31(4): p. 381-390. 55. Ofosu FA. Review The Blood Platelet as a Model for Regulating Blood Coagulation on Cell Surfaces and Its Consequences. Biochemistry. 2005; 67(1): p. 47-55. 56. Topol E, Neumann F, Montalescot G. A Preferred Reperfusion Strategy for Acute Myocardial Infarction. J Am Coll Cardiol. 2003; 42: p. 1886-1889. 57. Campo G, Valgimigli M, Gemmati D, Percoco G, Tognazzo S, Cicchitelli G, et al. Value of Platelet Reactivity in Predicting Response to Treatment and Clinical Outcome in Patients Undergoing Primary Coronary Intervention Insights Into the STRATEGY Study. Journal of the American College of Cardiology. 2006; 48(11): p. 2179-2186.

42

58. Pereg D, Berin T, Mosseri M. Mean Platelet Volume on Admission Correlates With Impaired Response to Thrombolysis in Patients With ST-Elevation Myocardial Infarction. Platelets. 2010 March; 21(2): p. 117121. 59. Huon HG, Keith DD, M JM, S IA. Lecture Notes Cardiology, Erlangga Medical Series. 4th ed.. Jakarta: Erlangga. 60. Sylvia AP, Lorraine MW. Patofisiologi: Konsep Klinis Proses-Proses Penyakit. 6th ed. Jakarta: Penerbit Buku Kedokteran EGC; 2005. 61. Stern MP. The Recent Decline in Ischemic Heart Disease Mortality. Anals Intern M Ed. 1979; 91: p. 630-640. 62. Siregar T, Gumanti M. Hipertesi Esensial. In Rilantono dkk. Buku Ajar Kardiologi. Jakarta: FK UI; 2003. 63. Chobanian AV. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Complate Report. New York: National Institutes of Health; National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program, U.S. Department of Health and Human Service; 2004. 64. Peng CF, Kane JJ, Jones EM, Murphy ML, Straub KD, Doherty JE. The Adverse Effect of Systemic Hypertension Following Myocardial Reperfusion. Journal of Surgical Research. 1983 January; 34(1): p. 59-67. 65. Podesser BK, Apstein CS, Ngoy S, Jain M, Eberti FR. Hypertension Induced Left Ventricular Hypertrophy in Females is Associated With Reduced Tolerance to Ischemia and Reperfusion. Journal of the American College of Cardiology. 1998 February; 31(2): p. 49. 66. Gender and Hypertension Independently Influence Susceptibility to IschemiaReperfusion Injury Post-Myocardial Infarction. Journal of Cardiac Failure. 1998 September; 4(3): p. 14. 67. Berkel TM, Boersma H, Hesselink JW, Erdman RM, L SM. Impact of Smoking Cessation and Smoking Interventions in Patient with Coronary Heart Disease. Departement of Cardiology, Departement of Medical Psychology and Psychotherapy Heartcentre. Rotterdam, The Netherland. 1999; 20: p. 17731782. 68. Ridker PM, Ganest J, P L. Risk Factors for Atherosclerotic Disease. In Braunwald E. Heart Disease, A Text Book of Cardoivascular Medicine. 6th

43

ed. Philadelphia: WB Saunders co; 2001. p. 1010-1031. 69. Grines CL, Topol EL, George BS, Young SY, Kereiakis DJ, Phillips HR, et al. Effect of Cigarette Smoking on Outcome After Thrombolytic Therapy for Miocardial Infarction. J Am Col Cardiol. 1991 February; 7(2): p. 185. 70. Zahger D, Shah PK. Effect of Smoking Status on Response to Thrombolytic Therapy. J Am Col Cardiol. 1996 July; 28(1): p. 283. 71. Rivers JT, White HD, Cross DB, Williams BF, Norris RM. Reinfarction After Thrombolytic Therapy for Acute Myocardial Infarction Followed by Conservative Management : Incidence and Effect of Smoking. J Am Col Cardiol. 1990 August; 16(2): p. 340-348. 72. Lundergan CF, Reiner JS, McCarthy WF, Coyne KS, Califf RM, Ross AM. Clinical Predictors of Early Infarct-Related Artery Patency Following Thrombolytic Therapy: Importance of Body Weight, Smoking History, Infarct-Related Artery and Choice of Thrombolytic Regimen: The GUSTO-I Experience. J Am Col Cardiol. 1998 September; 32(3): p. 641-647. 73. Dahlan MS. Langkah-Langkah Membuat Proposal Penelitian Bidang Kedokteran dan Kesehatan. 2nd ed. Jakarta: CV. Sagung Seto; 2010. 74. Soekidjo N. Metodologi Penelitian Kesehatan. Edisi Revisi ed. Jakarta: Penerbit Rineka Cipta; 2006. 75. Sastroasmoro S, Ismail S. Dasar-Dasar Metodologi Penelitian Klinis. 4th ed. Jakarta: CV. Sagung Seto; 2011. 76. Dahlan MS. Besar Sampel dan Cara Pengambilan Sampel dalam Penelitian Kedokteran dan Kesehatan Jakarta: Penerbit Salemba Medika; 2010. 77. Richard AM, Matthew RP. Henry's Clinical Diagnosis and Management by Laboratory Methods. 22nd ed. New York: Saunders-Elsevier; 2012. 78. Frank E, Shubha M, D'Souza C. Blood Glucose Determination: Plasma or Serum? J Clin Lab Anal. 2012; 26(5): p. 317-20. 79. Dahlan MS. Statistik Kedokteran dan Kesehatan: Deskriptif, Bivariat, dan Multivariat Dilengkapi Aplikasi dengan Menggunakan SPSS. 5th ed. Jakarta: Penerbit Salameba Medika; 2012.